[On the quantitative effectiveness of k-strophanthin-alpha (Cymarin) in intravenous and oral administration].
D001281:Atrial Fibrillation / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D013328:Strophanthins / Q000008:administration & dosage* / Q000378:metabolism; D013997:Time Factors
D004071:Digitalis Glycosides; D013328:Strophanthins
Uber die quantitative Wirksamkeit von k-Strophanthin-alpha (Cymarin) bei intravenöser und oraler Applikation.